Publications by authors named "Suganthini Nanthakumar"

Claim this Profile
S
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease.
Brandon Zimmerman, Leslie A Dakin, Anne Fortier, Evanthia Nanou, Angelo Blasio, Suganthini Nanthakumar

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.
Jon H Come, Timothy J Senter, Michael P Clark, John J Court, Zachary Gale-Day, Suganthini Nanthakumar

J Med Chem· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
Upul K Bandarage, John Court, Huai Gao, Suganthini Nanthakumar, Jon H Come

Bioorg Med Chem Lett· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates.
Pan Li, Warren Dorsch, David J Lauffer, Darius Bilimoria, Nathalie Chauret, Suganthini Nanthakumar

ACS Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors.
Dominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, Christine Memmott, Derek Lowe

J Med Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.
Mark W Ledeboer, Albert C Pierce, John P Duffy, Huai Gao, David Messersmith, Suganthini Nanthakumar

Bioorg Med Chem Lett· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.
Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, Guy W Bemis, Jingrong Cao, Suganthini Nanthakumar

J Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).
Luc J Farmer, Guy Bemis, Shawn D Britt, John Cochran, Martin Connors, Suganthini Nanthakumar

Bioorg Med Chem Lett· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput manual parallel synthesis using SynPhase crowns and lanterns.
Samuel W Gerritz, Mark H Norman, Lee A Barger, Judd Berman, Eric C Bigham, Suganthini S Nanthakumar

J Comb Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis